ArticleBiogerontology2026
Nacre extract attenuates age-related functional and tissue alterations under post-onset intervention conditions in two murine aging models.
Article in Biogerontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aging is accompanied by the accumulation of senescent cells and chronic low-grade inflammation, which together contribute to functional decline and tissue remodeling across organs. We previously reported that long-term nacre extract supplementation can delay age-related deterioration when initiated early; however, whether it can provide benefit under post-onset intervention conditions remains unclear. Here, we evaluated a water-soluble nacre extract derived from Pinctada fucata using (i) senescence-accelerated mouse prone 8 (SAMP8) mice and (ii) a D-galactose-induced aging paradigm, with treatment administered after the emergence of age-related phenotypes. In SAMP8 mice, nacre extract improved cognitive and neuromuscular performance, including Y-maze spontaneous alternation, novel object recognition, and forelimb grip strength, and showed a partial improvement in composite aging indices. These benefits were accompanied by reduced senescence-associated markers (p16, p21, and phosphorylated histone H2AX (γH2AX)) in skeletal muscle and peripheral organs, suppression of inflammation-associated signaling in skeletal muscle, and improved redox-related marker profiles. Nacre extract also increased satellite cell- and contractile marker-related immunoreactivity in aged skeletal muscle, suggesting improved regeneration- and maturation-related tissue characteristics. In the D-galactose model, nacre extract was introduced after impairments emerged and administered during the final 11 weeks of continued D-galactose exposure; under these post-onset intervention conditions, nacre extract improved grip strength, showed trends toward improved cognitive performance, and reduced senescence-associated markers in skeletal muscle and adipose tissue, supporting reproducibility across paradigms. Collectively, these findings indicate that nacre extract attenuates aging-associated functional and tissue alterations under post-onset intervention conditions by attenuating senescence- and inflammation-associated tissue responses and improving organism-level homeostasis.
Indexed as
Identifiers
42289617What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.